PTPN22 and cancer: It includes receptors that have been mechanistically linked to cancer progression such as the G protein coupled receptors CXCR3 and FZD6, linked to tumor cell growth, invasion and migration (62–64), and PTPN22, a protein tyrosine phosphatase associated with inhibition of antioncogenic immune response (65).